Company Filing History:
Years Active: 2015
Title: Gregory Robert Stewart: Innovator in Neurological Treatment
Introduction
Gregory Robert Stewart is a notable inventor based in Plymouth, MN (US). He has made significant contributions to the field of neurological disorders through his innovative work. His expertise and dedication to improving treatment options have led to the development of a unique patent.
Latest Patents
Stewart holds a patent for the "Treatment of neurological disorders." This invention provides treatment compositions as well as systems and methods for determining and administering an effective amount of treatment for a neurological disorder. The treatment composition can contain a labeled interfering RNA (iRNA) agent capable of decreasing the expression of a target RNA associated with the neurological disorder. The methods of the invention include determining an effective amount of a therapeutic composition by introducing a solution containing a tracer into the brain of a mammal. The tracing solution is monitored until a target volume of distribution at steady state distribution is substantially achieved, and the rate of delivery of the therapeutic composition is determined. The therapeutic composition can then be administered at the rate determined by the use of the tracing solution.
Career Highlights
Gregory Robert Stewart is currently associated with Medtronic, Inc., a leading company in medical technology. His work at Medtronic has allowed him to focus on innovative solutions for complex medical challenges. Stewart's contributions have been instrumental in advancing treatment methodologies for neurological conditions.
Collaborations
Stewart has collaborated with notable colleagues, including Dinah W Y Sah and Andrei P Guzaev. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Gregory Robert Stewart's work in the treatment of neurological disorders exemplifies the impact of innovation in healthcare. His patent and contributions to Medtronic, Inc. highlight his commitment to improving patient outcomes through advanced medical solutions.